4 ms·
Yes. Potentially life-saving drugs in RCTs are usually compared to "standard of care," i.e. already-approved treatments, not to placebos.
by FeteCommuniste 3mo ago
Yes. Potentially life-saving drugs in RCTs are usually compared to "standard of care," i.e. already-approved treatments, not to placebos.
- qsera 3mo agoSo if both the standard of care as well as the drug being trials have the same side effects, would they be included in the package insert/drug literature? Because the incidence rate of it would be same for both the groups?